These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29033569)

  • 21. Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey.
    Sacchetti E; Frank E; Siracusano A; Racagni G; Vita A; Turrina C
    Int Clin Psychopharmacol; 2015 May; 30(3):129-41. PubMed ID: 25828864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal cutoff point of the Hamilton Rating Scale for Depression according to normal levels of social and occupational functioning.
    Romera I; Pérez V; Menchón JM; Polavieja P; Gilaberte I
    Psychiatry Res; 2011 Mar; 186(1):133-7. PubMed ID: 20659770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the psychometric properties of the 17- and 6-item Hamilton Depression Rating Scales in major depressive disorder, bipolar depression and bipolar depression with mixed features.
    Kieslich da Silva A; Reche M; Lima AFDS; Fleck MPA; Capp E; Shansis FM
    J Psychiatr Res; 2019 Jan; 108():84-89. PubMed ID: 30055852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?
    Fava M; Mallinckrodt CH; Detke MJ; Watkin JG; Wohlreich MM
    J Clin Psychiatry; 2004 Apr; 65(4):521-30. PubMed ID: 15119915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Improvements in Individual Symptoms to Predict Later Remission in Major Depressive Disorder Treated With Mirtazapine.
    Funaki K; Nakajima S; Suzuki T; Mimura M; Uchida H
    J Clin Pharmacol; 2016 Sep; 56(9):1111-9. PubMed ID: 26813241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of painful physical symptoms on depression outcomes in elderly Asian patients.
    Novick D; Montgomery W; Bertsch J; Peng X; Brugnoli R; Haro JM
    Int Psychogeriatr; 2014 Nov; ():1-8. PubMed ID: 25366979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Painful Physical Symptoms and Clinical Outcomes in Korean Patients with Major Depressive Disorder: A Three-Month Observational Study.
    Lee MS; Yum SY; Hong JP; Yoon SC; Noh JS; Lee KH; Kim JK; Lee SY; Singh P; Treuer T; Reed V; Raskin J
    Psychiatry Investig; 2009 Dec; 6(4):255-63. PubMed ID: 20140123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes and Prediction of Social Functional Disability and Quality of Life in Patients with Major Depressive Disorder over the Course of 1-Year Medication].
    Wang JY; Yuan ML; Zhang W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):904-910. PubMed ID: 36224695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between painful physical symptoms and clinical outcomes in Chinese patients with major depressive disorder: a three-month observational study.
    Li HC; Zhang MY; Wang G; Zhang HG; Zhang HY; Liu Y; Li M; Zhang CP; Tang JS; Wu WY; Singh P; Granger RE; Raskin J; Ang QQ
    Chin Med J (Engl); 2010 Aug; 123(15):2063-9. PubMed ID: 20819543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Relationship Between Baseline Clinical Symptom Characteristics and Working Ability in Japanese Patients Treated for Major Depressive Disorder and Painful Physical Symptoms.
    Sugawara N; Yasui-Furukori N; Tsuji T; Hayashi S; Ajisawa Y; Ochiai T; Imagawa H; Shimoda K
    Neuropsychiatr Dis Treat; 2020; 16():3063-3070. PubMed ID: 33335397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial.
    Gaynes BN; Rush AJ; Trivedi M; Wisniewski SR; Balasubramani GK; Spencer DC; Petersen T; Klinkman M; Warden D; Schneider RK; Castro DB; Golden RN
    Gen Hosp Psychiatry; 2005; 27(2):87-96. PubMed ID: 15763119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
    Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
    J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of desvenlafaxine 50 mg compared with placebo in patients with moderate or severe major depressive disorder: a pooled analysis of six randomized, double-blind, placebo-controlled studies.
    Papakostas GI; Culpepper L; Fayyad RS; Musgnung J; Guico-Pabia CJ
    Int Clin Psychopharmacol; 2013 Nov; 28(6):312-21. PubMed ID: 23881185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multicenter, observational study of pain and functional impairment in individuals with major depressive disorder in partial remission: the DESIRE study.
    Pérez V; Martínez-Navarro R; Pérez-Aranda A; Martínez-Sadurní L; Arranz-Estévez FJ; Colom F; Pujol J; Toll A; Iniesta-Terré M; Elices M
    J Affect Disord; 2021 Feb; 281():657-660. PubMed ID: 33246652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of metabolic syndrome and thyroid hormone on efficacy of desvenlafaxine 50 and 100 mg/d in major depressive disorder.
    McIntyre RS; Fayyad R; Mackell JA; Boucher M
    Curr Med Res Opin; 2016; 32(3):587-99. PubMed ID: 26709542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder.
    Endicott J; Lam RW; Hsu MA; Fayyad R; Boucher M; Guico-Pabia CJ
    J Affect Disord; 2014 Sep; 166():307-14. PubMed ID: 25012446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotic symptoms and neurocognition among patients with major depressive disorder: A chained mediation model of depressive symptoms and socio-occupational functioning.
    Zeng Y; Zhang F; Liu H; Li W; Ning Y; Zhou Y
    J Affect Disord; 2023 Jul; 332():194-200. PubMed ID: 37044284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broader conceptualization of remission assessed by the remission from depression questionnaire and its association with symptomatic remission: a prospective, multicenter, observational study.
    Montoya A; Lebrec J; Keane KM; Fregenal I; Ciudad A; Moríñigo Á; Agüera-Ortiz L; Romera I; Gilaberte I; Zimmerman M
    BMC Psychiatry; 2016 Oct; 16(1):352. PubMed ID: 27760534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between painful physical symptoms and severity of depressive symptomatology and suicidality.
    Bahk WM; Park S; Jon DI; Yoon BH; Min KJ; Hong JP
    Psychiatry Res; 2011 Oct; 189(3):357-61. PubMed ID: 21329990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.